BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 29, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Phase Ia clinical trial with NIF for ischemic stroke completed by Pfizer
July 7, 1998
CNS-selective effects of synthetic, nonfeminizing estrogens
July 7, 1998
New antimigraine option now available in Canada
July 7, 1998
Ganaxolone study results presented at AASH meeting
July 7, 1998
Taisho claims potent and selective D4 receptor antagonists
July 7, 1998
OPC-14117: tolerability and safety as antioxidant therapy for Huntington's disease
July 7, 1998
S-8510 enhances cognition and acetylcholine release in basal forebrain-lesioned rats
July 6, 1998
CNI-1493 treatment associated with improvement in mouse model of MS
July 6, 1998
Nihon Nohyaku claims arylpiperidines for schizophrenia, dementia
July 6, 1998
Berlex and Chiron file with FDA to treat progressive form of MS
July 6, 1998
Previous
1
2
…
2599
2600
2601
2602
2603
2604
2605
2606
2607
…
2816
2817
Next
RSS